{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:09:10Z","timestamp":1776197350091,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Scientific and Technological Personnel Support Program of Shaanxi Provincial People's Hospital","award":["2021LJ-07"],"award-info":[{"award-number":["2021LJ-07"]}]},{"name":"the Scientific and Technological Personnel Support Program of Shaanxi Provincial People's Hospital","award":["2021LJ-07"],"award-info":[{"award-number":["2021LJ-07"]}]},{"name":"the Scientific and Technological Personnel Support Program of Shaanxi Provincial People's Hospital","award":["2021LJ-07"],"award-info":[{"award-number":["2021LJ-07"]}]},{"name":"the Scientific and Technological Personnel Support Program of Shaanxi Provincial People's Hospital","award":["2021LJ-07"],"award-info":[{"award-number":["2021LJ-07"]}]},{"name":"Key Research and Development plan of Shaanxi Province","award":["2019ZDLSF03-0570"],"award-info":[{"award-number":["2019ZDLSF03-0570"]}]},{"name":"Key Research and Development plan of Shaanxi Province","award":["2019ZDLSF03-0570"],"award-info":[{"award-number":["2019ZDLSF03-0570"]}]},{"name":"Key Research and Development plan of Shaanxi Province","award":["2019ZDLSF03-0570"],"award-info":[{"award-number":["2019ZDLSF03-0570"]}]},{"name":"Key Research and Development plan of Shaanxi Province","award":["2019ZDLSF03-0570"],"award-info":[{"award-number":["2019ZDLSF03-0570"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-025-00234-x","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:01:25Z","timestamp":1746183685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A new Tec family-based clinical model predicts survival in differentiated thyroid cancer patients via machine learning"],"prefix":"10.1186","volume":"18","author":[{"given":"Ziyu","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"234_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409\u201336.","journal-title":"CA Cancer J Clin"},{"key":"234_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1089\/thy.2016.0477","volume":"27","author":"S Park","year":"2017","unstructured":"Park S, Kim WG, Song E, Oh HS, Kim M, et al. Dynamic risk stratification for predicting recurrence in patients with differentiated thyroid cancer treated without radioactive iodine remnant ablation therapy. Thyroid. 2017;27:524\u201330.","journal-title":"Thyroid"},{"key":"234_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/biom11040503","volume":"11","author":"JOS Onyeisi","year":"2021","unstructured":"Onyeisi JOS, Lopes CC, G\u00f6tte M. Syndecan-4 as a pathogenesis factor and therapeutic target in cancer. Biomolecules. 2021;11:503.","journal-title":"Biomolecules"},{"key":"234_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semcancer.2020.11.013","volume":"79","author":"P Fallahi","year":"2022","unstructured":"Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, et al. Molecular targets of tyrosine kinase inhibitors in thyroid cancer. Semin Cancer Biol. 2022;79:180\u201396.","journal-title":"Semin Cancer Biol"},{"issue":"3\u20134","key":"234_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1359-6101(99)00019-2","volume":"10","author":"H Mano","year":"1999","unstructured":"Mano H. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Factor Rev. 1999;10(3\u20134):267\u201380.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Pt 15","key":"234_CR6","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1242\/jcs.115.15.3039","volume":"115","author":"AFL Takesono","year":"2002","unstructured":"Takesono AFL, Schwartzberg PL. Beyond calcium: new signaling pathways for Tec family kinases. J Cell Sci. 2002;115(Pt 15):3039\u201348.","journal-title":"J Cell Sci"},{"key":"234_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41420-022-00927-4","volume":"8","author":"Z Yin","year":"2022","unstructured":"Yin Z, Zou Y, Wang D, Huang X, Xiong S, et al. Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease. Cell Death Discov. 2022;8:119.","journal-title":"Cell Death Discov"},{"key":"234_CR8","doi-asserted-by":"publisher","first-page":"104377","DOI":"10.1016\/j.bioorg.2020.104377","volume":"105","author":"W Huang","year":"2020","unstructured":"Huang W, Wang S, Zhang Z, Zhang C, Zeng S, et al. HZ-A-005, a potent, selective, and covalent Bruton\u2019s tyrosine kinase inhibitor in preclinical development. Bioorganic Chem. 2020;105:104377.","journal-title":"Bioorganic Chem"},{"key":"234_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/13543784.2016.1182499","volume":"25","author":"P Norman","year":"2016","unstructured":"Norman P. Investigational Bruton\u2019s tyrosine kinase inhibitors for the treatment of rheumatoid arthritis. Expert Opin Investig Drugs. 2016;25:891\u20139.","journal-title":"Expert Opin Investig Drugs"},{"issue":"16","key":"234_CR10","doi-asserted-by":"publisher","first-page":"16437","DOI":"10.18632\/aging.103710","volume":"12","author":"JLB Wen","year":"2020","unstructured":"Wen JLB, Lin L, Chen Y, Wang O. KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression. Aging (Albany NY). 2020;12(16):16437\u201356.","journal-title":"Aging (Albany NY)"},{"key":"234_CR11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3892\/ijo.2017.4113","volume":"51","author":"Z Chang","year":"2017","unstructured":"Chang Z, Cai C, Han D, Gao Y, Li Q, et al. Anoctamin5 regulates cell migration and invasion in thyroid cancer. Int J Oncol. 2017;51:1311\u20139.","journal-title":"Int J Oncol"},{"key":"234_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6947-11-51","volume":"11","author":"M Khalilia","year":"2011","unstructured":"Khalilia M, Chakraborty S, Popescu M. Predicting disease risks from highly imbalanced data using random forest. BMC Med Inform Decis Mak. 2011;11:1.","journal-title":"BMC Med Inform Decis Mak"},{"key":"234_CR13","doi-asserted-by":"publisher","first-page":"104441","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104441","volume":"28","author":"Y Xu","year":"2019","unstructured":"Xu Y, Yang X, Huang H, Peng C, Ge Y, et al. Extreme gradient boosting model has a better performance in predicting the risk of 90-day readmissions in patients with ischaemic stroke. J Stroke Cerebrovasc Dis. 2019;28:104441.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"234_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2016","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2016;26:565\u201374.","journal-title":"Med Decis Making"},{"key":"234_CR15","doi-asserted-by":"crossref","unstructured":"Faouzi J, Colliot O. Classic machine learning methods. In: Machine learning for brain disorders. 2023:25\u201375.","DOI":"10.1007\/978-1-0716-3195-9_2"},{"key":"234_CR16","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.spinee.2015.06.043","volume":"15","author":"GS Collins","year":"2015","unstructured":"Collins GS, Ogundimu EO, Le Manach Y. Assessing calibration in an external validation study. Spine J. 2015;15:2446\u20137.","journal-title":"Spine J"},{"key":"234_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1186\/s12877-022-03430-8","volume":"22","author":"J Wang","year":"2022","unstructured":"Wang J, Zhanghuang C, Jin L, Zhang Z, Tan X, et al. Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study. BMC Geriatrics. 2022;22:736.","journal-title":"BMC Geriatrics"},{"key":"234_CR18","doi-asserted-by":"publisher","first-page":"e13665","DOI":"10.1016\/j.heliyon.2023.e13665","volume":"9","author":"J Tang","year":"2023","unstructured":"Tang J, Zhanghuang C, Yao Z, Li L, Xie Y, et al. Development and validation of a nomogram to predict cancer-specific survival in middle-aged patients with papillary thyroid cancer: a SEER database study. Heliyon. 2023;9:e13665.","journal-title":"Heliyon"},{"key":"234_CR19","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.21037\/gs-21-100","volume":"10","author":"Y-M Cao","year":"2021","unstructured":"Cao Y-M, Zhang T-T, Li B-Y, Qu N, Zhu Y-X. Prognostic evaluation model for papillary thyroid cancer: a retrospective study of 660 cases. Gland Surg. 2021;10:2170\u20139.","journal-title":"Gland Surg"},{"issue":"3","key":"234_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/EJE-21-0365","volume":"185","author":"EFSPR van Velsen","year":"2021","unstructured":"van Velsen EFSPR, Stegenga MT, van Kemenade FJ, van Ginhoven TM, Verburg FA, Visser WE. The influence of age on disease outcome in 2015 ATA high-risk differentiated thyroid cancer patients. Eur J Endocrinol. 2021;185(3):421\u20139.","journal-title":"Eur J Endocrinol"},{"key":"234_CR21","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1089\/thy.2015.0104","volume":"25","author":"I Ganly","year":"2015","unstructured":"Ganly I, Nixon IJ, Wang LY, Palmer FL, Migliacci JC, et al. Survival from differentiated thyroid cancer: what has age got to do with it? Thyroid. 2015;25:1106\u201314.","journal-title":"Thyroid"},{"key":"234_CR22","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.21037\/tcr-24-247","volume":"13","author":"H Peng","year":"2024","unstructured":"Peng H, Zheng M, Li JY, Jin Z. Analysis of the ideal cutoff age as a predictor of differentiated thyroid cancer using the Surveillance, Epidemiology, and End Results database. Transl Cancer Res. 2024;13:4278\u201389.","journal-title":"Transl Cancer Res"},{"key":"234_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.4158\/EP151139.OR","volume":"22","author":"P Chen","year":"2016","unstructured":"Chen P, Feng HJ, Ouyang W, Wu JQ, Wang J, et al. Risk factors for nonremission and progression-free survival after I-131 therapy in patients with lung metastasis from differentiated thyroid cancer: a single-institute, retrospective analysis in Southern China. Endocr Pract. 2016;22:1048\u201356.","journal-title":"Endocr Pract"},{"key":"234_CR24","first-page":"1067447","volume":"2024","author":"PO Luis","year":"2024","unstructured":"Luis PO, Luc\u00eda MJA, Hugo RC, Ramiro RM, Stalin CQ, et al. Differentiated thyroid carcinoma long-term prognostic factors. Int J Surg Oncol. 2024;2024:1067447.","journal-title":"Int J Surg Oncol"},{"key":"234_CR25","doi-asserted-by":"publisher","first-page":"862313","DOI":"10.3389\/fonc.2022.862313","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wang Y, Li D, Le Y, Han Y, et al. Single-Cell RNA sequencing revealed a 3-gene panel predicted the diagnosis and prognosis of thyroid papillary carcinoma and associated with tumor immune microenvironment. Front Oncol. 2022;12:862313.","journal-title":"Front Oncol"},{"key":"234_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02389-7","volume":"21","author":"J Shi","year":"2021","unstructured":"Shi J, Wu P, Sheng L, Sun W, Zhang H. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma. Cancer Cell Int. 2021;21:1.","journal-title":"Cancer Cell Int"},{"issue":"Pt A","key":"234_CR27","doi-asserted-by":"publisher","first-page":"108156","DOI":"10.1016\/j.intimp.2021.108156","volume":"101","author":"YXZ Huang","year":"2021","unstructured":"Huang YXZ, Li X, Chen W, He Y, Wu S, Li X, Hou B, Sun J, Wang S, He Y, Jiang H, Lun Y, Zhang J. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma. Int Immunopharmacol. 2021;101(Pt A):108156.","journal-title":"Int Immunopharmacol"},{"key":"234_CR28","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1080\/07853890.2023.2192049","volume":"55","author":"Y Su","year":"2023","unstructured":"Su Y, Xu B, Li J, Shen Q, Lei Z, et al. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer. Ann Med. 2023;55:1298\u2013316.","journal-title":"Ann Med"},{"key":"234_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/cancers14051353","volume":"14","author":"W Wang","year":"2022","unstructured":"Wang W, Bai N, Li X. Comprehensive analysis of the prognosis and drug sensitivity of differentiation-related lncRNAs in papillary thyroid cancer. Cancers. 2022;14:1353.","journal-title":"Cancers"},{"key":"234_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.12998\/wjcc.v11.i1.92","volume":"11","author":"F Yang","year":"2023","unstructured":"Yang F, Zhou YL. Identification of a four-miRNA signature predicts the prognosis of papillary thyroid cancer. World J Clin Cases. 2023;11:92\u2013103.","journal-title":"World J Clin Cases"},{"key":"234_CR31","first-page":"1","volume":"2022","author":"Y Ding","year":"2022","unstructured":"Ding Y, Li P, Wang W, Liu F, Hashmi AA. A potential four-gene signature and nomogram for predicting the overall survival of papillary thyroid cancer. Dis Markers. 2022;2022:1\u201331.","journal-title":"Dis Markers"},{"key":"234_CR32","doi-asserted-by":"publisher","first-page":"1062317","DOI":"10.3389\/fendo.2023.1062317","volume":"14","author":"M Xia","year":"2023","unstructured":"Xia M, Wang S, Wang L, Mei Y, Tu Y, et al. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer. Front Endocrinol. 2023;14:1062317.","journal-title":"Front Endocrinol"},{"key":"234_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/08830185.2012.671692","volume":"31","author":"M Faris","year":"2012","unstructured":"Faris M, Bot A. In this issue: Tec kinases in the crosshairs. Int Rev Immunol. 2012;31:85\u20136.","journal-title":"Int Rev Immunol"},{"key":"234_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2010.11.068","volume":"404","author":"F Li","year":"2011","unstructured":"Li F, Jiang Y, Zheng Q, Yang X, Wang S. TEC protein tyrosine kinase is involved in the Erk signaling pathway induced by HGF. Biochem Biophys Res Commun. 2011;404:79\u201385.","journal-title":"Biochem Biophys Res Commun"},{"key":"234_CR35","first-page":"e4068","volume":"11","author":"STLW Shu","year":"2021","unstructured":"Shu STLW, Smithgall TE. Visualization of host cell kinase activation by viral proteins using GFP fluorescence complementation and immunofluorescence microscopy. Bio-Protocol. 2021;11:e4068.","journal-title":"Bio-Protocol"},{"key":"234_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ctrv.2017.06.001","volume":"58","author":"J Molina-Cerrillo","year":"2017","unstructured":"Molina-Cerrillo J, Alonso-Gordoa T, Gajate P, Grande E. Bruton\u2019s tyrosine kinase (BTK) as a promising target in solid tumors. Cancer Treat Rev. 2017;58:41\u201350.","journal-title":"Cancer Treat Rev"},{"key":"234_CR37","doi-asserted-by":"publisher","first-page":"37651","DOI":"10.1074\/jbc.M311985200","volume":"279","author":"LA Humphries","year":"2004","unstructured":"Humphries LA, Dangelmaier C, Sommer K, Kipp K, Kato RM, et al. Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase C\u03b3 Src homology 2-Src homology 3 linker. J Biol Chem. 2004;279:37651\u201361.","journal-title":"J Biol Chem"},{"key":"234_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-065X.2007.00534.x","volume":"218","author":"JRJ Gomez-Rodriguez","year":"2007","unstructured":"Gomez-Rodriguez JRJ, Viorritto IC, Mueller KL, Houghtling RA, Schwartzberg PL. Tec kinases, actin, and cell adhesion. Immunol Rev. 2007;218:45\u201364.","journal-title":"Immunol Rev"},{"key":"234_CR39","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1021\/cb4008524","volume":"9","author":"H Wu","year":"2014","unstructured":"Wu H, Wang W, Liu F, Weisberg EL, Tian B, et al. Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma. ACS Chem Biol. 2014;9:1086\u201391.","journal-title":"ACS Chem Biol"},{"key":"234_CR40","doi-asserted-by":"publisher","first-page":"e1409","DOI":"10.1038\/cddis.2014.343","volume":"5","author":"W Guo","year":"2014","unstructured":"Guo W, Liu R, Bhardwaj G, Yang JC, Changou C, et al. Targeting Btk\/Etk of prostate cancer cells by a novel dual inhibitor. Cell Death Dis. 2014;5:e1409\u2013e1409.","journal-title":"Cell Death Dis"},{"key":"234_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/10428194.2013.794458","volume":"55","author":"Y Liu","year":"2013","unstructured":"Liu Y, Dong Y, Jiang QL, Zhang B, Hu AM. Bruton\u2019s tyrosine kinase: potential target in human multiple myeloma. Leuk Lymphoma. 2013;55:177\u201381.","journal-title":"Leuk Lymphoma"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00234-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-025-00234-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00234-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:38:15Z","timestamp":1746520695000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-025-00234-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1186\/s13044-025-00234-x","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}